198 related articles for article (PubMed ID: 11652865)
1. Funding innovative medical treatment.
Holder AR
Albany Law Rev; 1994; 57(3):795-810. PubMed ID: 11652865
[No Abstract] [Full Text] [Related]
2. Medical insurance payments and patients involved in research.
Holder AR
IRB; 1994; 16(1-2):19-22. PubMed ID: 11652323
[No Abstract] [Full Text] [Related]
3. Who should rightfully decide whether a medical treatment necessarily incurred should be excluded from coverage under a health insurance policy provision which excludes from coverage "experimental" medical treatments?
Fisfis BA
Duquesne Law Rev; 1993; 31(4):777-800. PubMed ID: 11652669
[No Abstract] [Full Text] [Related]
4. Undefined experimental treatment exclusions in health insurance contracts: a proposal for judicial response.
Belk J
Wash Law Rev; 1991 Jul; 66(3):809-30. PubMed ID: 11652624
[No Abstract] [Full Text] [Related]
5. Medical necessity, AIDS, and the law.
Schultz GP; Pormenter CA
St Louis Univ Public Law Rev; 1990; 9(2):379-420. PubMed ID: 11651112
[No Abstract] [Full Text] [Related]
6. Emerging technologies and medical coverage.
Merrikin K; Smith S
Clin Ethics Rep; 1996; 10(1):9-12. PubMed ID: 11660222
[No Abstract] [Full Text] [Related]
7. Getting new drugs to people with AIDS: a public policy response to Lansdale.
Cohen MN
Hastings Constit Law Q; 1991; 18(3):471-85. PubMed ID: 11651493
[No Abstract] [Full Text] [Related]
8. AIDS and access to care: lessons for health care reformers.
Isbell MT
Cornell J Law Public Policy; 1993; 3():7-53. PubMed ID: 11656592
[No Abstract] [Full Text] [Related]
9. AIDS and the American health care financing system.
Greely HT
Univ Pittsbg Law Rev; 1989; 51(1):73-166. PubMed ID: 11652563
[No Abstract] [Full Text] [Related]
10. If a subject incurs obligations and carries them out, then consent is a contract: Dahl v. HEM Pharmaceuticals (Part II).
Maloney DM
Hum Res Rep; 1996 Jan; 11(1):4-5. PubMed ID: 11653221
[No Abstract] [Full Text] [Related]
11. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
12. Cost containment and the standard of medical care.
Morreim EH
Calif Law Rev; 1987 Oct; 75(5):1719-63. PubMed ID: 11659107
[No Abstract] [Full Text] [Related]
13. Despite "clinical hold," subjects have right to keep getting experimental drug: Dahl v. HEM Pharmaceuticals Corporation (Part III).
Maloney DM
Hum Res Rep; 1996 Feb; 11(2):4-5. PubMed ID: 11654437
[No Abstract] [Full Text] [Related]
14. The AIDS epidemic and health care reform.
Bradford WA; Zavos MA;
John Marshall Law Rev; 1994; 27(2):279-315. PubMed ID: 11654694
[No Abstract] [Full Text] [Related]
15. The clinical-trials bottleneck.
Russo F
Atl Mon; 1999 May; 283(5):30, 32, 34, 36. PubMed ID: 11657639
[No Abstract] [Full Text] [Related]
16. Setting limits in the dying zone: assisted suicide, scarce resources, and hard cases.
Furrow BR
Univ Detroit Mercy Law Rev; 1995; 72(4):901-26. PubMed ID: 11654374
[No Abstract] [Full Text] [Related]
17. How we ration and allocate health care resources.
Brodeur D
Issues (St Louis Mo); 1996; 11(6):1-8. PubMed ID: 11660262
[No Abstract] [Full Text] [Related]
18. Medical necessity: a helpful concept?
Norris PF
Health Care Ethics USA; 1999; 7(3):2-3. PubMed ID: 11657774
[No Abstract] [Full Text] [Related]
19. Health care providers, insurers, and individual patients; the right to treatment; economic and policy issues.
Stoddard JC; Billings PR; Astrue MJ; Tennenbaum D; Lynch EC
Suffolk Univ Law Rev; 1993; 27(4):1499-523. PubMed ID: 11657047
[No Abstract] [Full Text] [Related]
20. Preventing patient dumping: sharpening the COBRA's fangs.
Treiger KI
N Y Univ Law Rev; 1987 Dec; 61(6):1186-223. PubMed ID: 11659026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
